October 26, 2016 4:42 PM ET

Life Sciences Tools and Services

Company Overview of SomaLogic, Inc.

Company Overview

SomaLogic, Inc. discovers, develops, and commercializes life science research tools and clinical diagnostic products for biological and medical science applications. It offers SOMAMER REAGENT, a proteomic platform that combines the properties of antibodies and aptamers; and SOMAscan assay, a protein biomarker discovery and development tool for protein measurement solutions. The company also provides diagnostic tests for various diseases and conditions. In addition, it offers protein-measurement assays, kits, and reagents for life science and biopharma researchers. Further, the company also provides protein biomarker-based diagnostics; and chemical reagents as potential therapeutic molecules....

2945 Wilderness Place

Boulder, CO 80301

United States

Founded in 1999





Key Executives for SomaLogic, Inc.

Chief Executive Officer and Director
Age: 60
Founder and Chairman of the Board
Age: 74
Chief Financial Officer
Director of Operations
Chief Medical Officer
Age: 56
Compensation as of Fiscal Year 2016.

SomaLogic, Inc. Key Developments

SomaLogic, Inc. Presents at Deutsche Bank 41st Annual Health Care Conference 2016, May-04-2016 through May-05-2016

SomaLogic, Inc. Presents at Deutsche Bank 41st Annual Health Care Conference 2016, May-04-2016 through May-05-2016. Venue: The InterContinental Hotel, 510 Atlantic Ave, Boston, Massachusetts, United States. Presentation Date & Speakers: May-04-2016, Byron D. Hewett, Chief Executive Officer and Director.

SomaLogic, Inc. Signs an Agreement with Bristol-Myers Squibb Company to Provide Expanded Access to its Proprietary SOMAmer Reagents

SomaLogic, Inc. announced that it has signed an agreement with the Bristol-Myers Squibb Company to provide expanded access to its proprietary SOMAmer reagents. The agreement covers both the 1,310 reagents available in the current public version of the SOMAscan assay as well as custom SOMAmer reagents developed through SomaLogic's SOMAmer Discovery Service specifically for Bristol-Myers Squibb. Specific terms of the agreement were not disclosed. SOMAmerA (Slow Off-rate Modified Aptamer) reagents are a new generation of protein-binding molecules that combine the best properties of antibodies and traditional aptamers. Each SOMAmerA reagent consists of a unique short single-stranded DNA sequence that incorporates several bases that have been modified to include "protein-like" side chains. These unique chemical properties confer on SOMAmer reagents both high affinity and specificity for their target proteins as well as high durability and reproducibility, making them attractive reagents for virtually every laboratory assay that currently relies on antibodies.

SomaLogic, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 09:40 AM

SomaLogic, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 09:40 AM. Venue: Westin Grand Central, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Private Placement
March 1, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SomaLogic, Inc., please visit www.somalogic.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.